Por: Irish Pharmaceutical Healthcare Association

New medicines can be life changing for people in Ireland. IPHA’s ‘Life. Because of New Medicines’ podcast series brings patients and industry representatives together, to hear how innovation and new medicines can literally change the trajectory of someone’s life. The podcasts document the personal stories from patients who, because of new medicines, were able to experience moments in their lives which otherwise wouldn’t have been possible. We’ll discuss the moments and experiences made possible, and why everyone in Ireland should have fast and fair access to the latest treatments available. The episodes, featuring four international biopharmaceutical companies with a presence in Ireland, centre around: Pfizer’s work towards the cancer moonshot goal and how clinical trials can accelerate these breakthroughs. Novo Nordisk’s has a long history in the development of medicines to treat chronic disease. Roche’s scientists are committed to finding new treatments that reduce the burden on patients with retinal diseases, which are a leading cause of sight loss. AbbVie’s researchers are driven to ensure that migraine sufferers have the option of new treatments that can help them live full lives. The Irish Pharmaceutical Healthcare Association (IPHA) represents the international research-based biopharmaceutical industry. The Innovate For Life campaign, which is in its sixth cycle, is the industry’s digital campaign demonstrating the impact of medicines innovation. Learn more about the Innovate For Life campaign at https://www.ipha.ie/news-events/innovation/innovateforlife/ Hosted on Acast. See acast.com/privacy for more information.

4 episodios disponibles